Analysts cut average target to USD 160.47 for Albemarle stock
Published on 10/20/2026 at 19:15 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSAnalyst target and earnings
- TradingView reported on October 19, 2026 that the average target fell to USD 160.47 across 17 analysts.
- Albemarle reported second-quarter revenue of USD 1.74 billion, up 31.10 percent year over year.
- Albemarle stock costs EUR 85.58 at Lang & Schwarz on October 20, 2026 at 7:09 p.m. CEST.
- The company is scheduled to report third-quarter results on November 4, 2026.
Albemarle Corp. (US0126531013) is facing a lower analyst benchmark after TradingView reported on October 19, 2026 that the average 12-month target had fallen from USD 161.88 to USD 160.47 across 17 analysts. The target stood 67.05 percent above the NYSE price of USD 96.06 at 1:13 p.m. EDT on October 20, 2026. After hours, the stock was trading at EUR 85.58 at Lang & Schwarz on October 20, 2026 at 7:09 p.m. CEST.
Target still implies a wide gap
The revised average target remains materially above the US share price, but its reduction gives investors a more cautious benchmark. TradingView reported a forecast range of USD 109.00 to USD 225.00 and 23 analysts with a consensus Buy rating on October 19, 2026.
The target reset follows several recent broker actions. MarketScreener listed BofA Securities cutting its target from USD 155.00 to USD 131.00 on October 19, 2026, while RBC cut its target from USD 157.00 to USD 129.00 on October 15, 2026.
Second-quarter growth sets the contrast
Zacks reported that Albemarle's second-quarter revenue reached USD 1.74 billion on August 5, 2026, up 31.10 percent from the prior-year quarter. Adjusted earnings per share rose to USD 3.75 from USD 0.11, while adjusted EBITDA increased 155.00 percent to USD 858.10 million.
Energy Storage revenue increased 77.90 percent to USD 1.28 billion in the second quarter of 2026, according to Zacks. Operating cash flow reached USD 710.00 million, although the source identified timing effects and non-recurring working-capital benefits in the conversion.
Range and reporting date
Albemarle's market capitalization was USD 11.3 billion on October 20, 2026. The 52-week range was USD 88.01 to USD 221.00, placing the US share 9.14 percent above its low. The next scheduled earnings release is November 4, 2026, according to the company's website.
For investors, the key contrast is clear: second-quarter operating figures improved sharply, while the average analyst target moved lower. The target remains a valuation reference rather than a forecast made by the company.
Price and investor context
Albemarle operates in specialty chemicals, with lithium, bromine and catalysts as its principal businesses. Its 7,800 employees serve customers in mobility, energy, connectivity and health, according to the company.
Albemarle was trading at EUR 85.58 at Lang & Schwarz on October 20, 2026 at 7:09 p.m. CEST. The further course of trading is shown by the continuously updated real-time quote of Albemarle stock.
Albemarle Corp. at a glance
- Company: Albemarle Corporation
- ISIN: US0126531013
- Ticker: ALB
- Primary exchange: NYSE
- Price Lang & Schwarz (as of October 20, 2026, 7:09 p.m. CEST): EUR 85.58
- Market capitalization: USD 11.3 billion (as of October 20, 2026)
- 52-week range: USD 88.01-221.00 (as of October 20, 2026)
- Sector / Industry: Basic Materials / Specialty Chemicals
- Next earnings date: November 4, 2026
Market context: Market report S&P 500.
